Medica

Navitus Welcomes New Members to the Board of Directors

Retrieved on: 
Dienstag, Mai 14, 2024
Professional Services, Health, Insurance, Health Insurance, Managed Care, General Health, Pharmaceutical, Best Buy, CDW, The Nature Conservancy, Optum, Organization, Trinity Health, Trustee, General Mills, CFO, Therapy, SSM Health, Senior, Huntington Bancshares, Pillsbury (brand), Elevance Health, Medica, Pharmacy, TCF Bank, Management

Navitus Health Solutions, LLC today announced two updates to its Board of Directors.

Key Points: 
  • Navitus Health Solutions, LLC today announced two updates to its Board of Directors.
  • Lisa Erickson will be joining the Board as a Board Member.
  • She is also a member of the Board of Directors of Medica Holding Company, which oversees its family of businesses, including Dean Health Plan.
  • Their collective industry and business expertise will not only contribute to strengthening our organization, but will further enable us to navigate the future with confidence and agility.” - David Fields, President and CEO of Navitus Health Solutions
    With these appointments, the Board of Directors consists of five Board Members, a Vice Chair and a Chair of the Board.

Catalyst by Wellstar Joins Plug and Play's Innovation Platform

Retrieved on: 
Freitag, Februar 16, 2024
Catalysis, Investment, Physician, Medica, Patient, Plug and play, Partnership

SUNNYVALE, Calif., Feb. 16, 2024 /PRNewswire/ -- Plug and Play has announced its partnership with Catalyst by Wellstar , the innovation and venture firm of one of Georgia's largest and most integrated health systems.

Key Points: 
  • SUNNYVALE, Calif., Feb. 16, 2024 /PRNewswire/ -- Plug and Play has announced its partnership with Catalyst by Wellstar , the innovation and venture firm of one of Georgia's largest and most integrated health systems.
  • Through the partnership, Plug and Play will assist Catalyst by Wellstar in deploying capital to early-stage technology companies in multiple industries and support digital transformation across the entire organization.
  • "Collaborating with Plug and Play allows Catalyst by Wellstar to expand its involvement with startups and offer more support to underrepresented entrepreneurs," said John D. Cooper, Head of Venture Investment for Catalyst by Wellstar.
  • The new partnership will provide Catalyst by Wellstar access to Plug and Play's ecosystem of 60k+ startups and receive investment sourcing and diligence support from Plug and Play Ventures.

Stuart Quin joins GHO Capital as Partner

Retrieved on: 
Donnerstag, Januar 4, 2024
GHO, Partner, Sale, Acquisition, Cinven, Medica, Doctor of Philosophy, Teleradiology, MEDICA Group, Diagnosis, IK Partners, Patient, Pharma, NHS, Capital, London Stock Exchange, Pharmaceutical industry

London, UK – 4 January 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce today that Stuart Quin joins as a Partner.

Key Points: 
  • London, UK – 4 January 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce today that Stuart Quin joins as a Partner.
  • Stuart, who holds a PhD in Immunology, has nearly two decades of experience within private equity, principally at 3i, and in healthcare leadership across Diagnostics, Pharma and Biotech.
  • The Partners at GHO Capital commented: “One of our core principles at GHO in the pursuit of better, faster and more accessible healthcare is that we don’t just invest in companies, we focus on strategic alignment and collaboration with management teams.
  • We are very excited to welcome Stuart to our leadership team to strengthen our ability to build the next generation of healthcare together.”
    Stuart Quin, Partner at GHO Capital, said: “GHO Capital is Europe’s leading healthcare specialist private equity firm, dedicated to making a difference for patients, healthcare systems, and society, whilst delivering long-term sustainable value to stakeholders.

Stuart Quin joins GHO Capital as Partner

Retrieved on: 
Donnerstag, Januar 4, 2024
GHO, Partner, Sale, Acquisition, Cinven, Medica, Doctor of Philosophy, Teleradiology, MEDICA Group, Diagnosis, IK Partners, Patient, Pharma, NHS, Capital, London Stock Exchange, Pharmaceutical industry

London, UK – 4 January 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce today that Stuart Quin joins as a Partner.

Key Points: 
  • London, UK – 4 January 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce today that Stuart Quin joins as a Partner.
  • Stuart, who holds a PhD in Immunology, has nearly two decades of experience within private equity, principally at 3i, and in healthcare leadership across Diagnostics, Pharma and Biotech.
  • The Partners at GHO Capital commented: “One of our core principles at GHO in the pursuit of better, faster and more accessible healthcare is that we don’t just invest in companies, we focus on strategic alignment and collaboration with management teams.
  • We are very excited to welcome Stuart to our leadership team to strengthen our ability to build the next generation of healthcare together.”
    Stuart Quin, Partner at GHO Capital, said: “GHO Capital is Europe’s leading healthcare specialist private equity firm, dedicated to making a difference for patients, healthcare systems, and society, whilst delivering long-term sustainable value to stakeholders.

Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business

Retrieved on: 
Freitag, November 17, 2023
Sale, Therapy, International, FDA, Allergic rhinitis, Growth, CHF, OTC, International Financial Reporting Standards, RNA, Medica

Hamilton, Bermuda, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira") (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced that it has entered into a binding agreement for the sale of a 51% stake in its subsidiary Altamira Medica AG (“Medica”) to a Swiss private equity investor as part of its strategic repositioning around its RNA delivery technology. Medica’s key asset is Bentrio®, a drug-free OTC nasal spray utilized for the treatment of allergic rhinitis, which has been cleared by the FDA and is being commercialized in a growing number of countries.

Key Points: 
  • Altamira has agreed to sell the 51% stake in Medica for a cash consideration of CHF 2,040,000 (about $2.3 million) and will retain 49% of the company’s share capital.
  • Further, Altamira will be entitled to receive 25% of Medica’s future licensing income.
  • Medica will continue its operations under its current name and with current staff in collaboration with Altamira.
  • “This marks an important first step in our strategic repositioning of the Company,” commented Thomas Meyer, Altamira Therapeutics’ founder, Chairman and CEO.

Medica Provides $500,000 for Food & Nutrition Security in Five States

Retrieved on: 
Dienstag, Dezember 5, 2023
Other Consumer, Food, Beverage, Other Health, Retail, Other Philanthropy, Insurance, Human Resources, Family, Hospitals, Fund Raising, Consumer, Foundation, Professional Services, Fitness & Nutrition, Philanthropy, General Health, Health, Health Insurance, Grain boundary strengthening, USA Today, Vegetable, Organization, Food security, Hunger, Agriculture, Medica

Medica has provided $500,000 in funding for food and nutrition security across five states.

Key Points: 
  • Medica has provided $500,000 in funding for food and nutrition security across five states.
  • The funding comes as America is facing its worst rate of hunger in years, according to a recent report from USA Today .
  • “I am hopeful that Medica’s contributions will help provide people in need with nutritional food choices,” said Lisa Erickson, Medica President and CEO.
  • “When we talk about food security the nutritional aspect of the issue often is missing in that conversation—nourishing our bodies with fruits, vegetables, whole grains.

Rhino Rescue Expands Horizons at Medica 2023, Exploring New Opportunities in the European Market

Retrieved on: 
Dienstag, November 28, 2023
Quality assurance, Multimedia, FDA, CE, Medica, Emergency medical services, Exhibition, Hunting, Medical device

During the event, more than 20 companies expressed their intention to partner with Rhino Rescue, thereby expanding its global prospects even further.

Key Points: 
  • During the event, more than 20 companies expressed their intention to partner with Rhino Rescue, thereby expanding its global prospects even further.
  • This appearance has presented Rhino Rescue with great opportunities to solidify its leading position in the emergency medical industry.
  • Rhino Rescue showcased its integrated tactical rescue solutions, featuring Flamor's cart stroller, which offers seamless patient transfer and treatment.
  • Embracing a localized approach, Rhino Rescue strives to create tailored solutions for different markets, ensuring optimal effectiveness and customer satisfaction.

dBio Unveils Cutting-Edge AIoT Health Innovations at Medica 2023

Retrieved on: 
Dienstag, November 14, 2023
Cloud, Research, Exercise, Stethoscope, GAIT, Artificial intelligence, Heart sounds, Health, Medica, Gait analysis, Software, Artificial intelligence of things, Medical device

TAIPEI, Nov. 14, 2023 /PRNewswire/ -- Get ready for an extraordinary health adventure with dBio at Medica 2023!

Key Points: 
  • TAIPEI, Nov. 14, 2023 /PRNewswire/ -- Get ready for an extraordinary health adventure with dBio at Medica 2023!
  • Decentralized Biotechnology Intelligence Co., Ltd (dBio) was awarded the 20th National Innovation Award for their latest solutions, the AIoT Wearable Stethoscope (StethoCloud) and AIoT Smart Insole Sensor (gMOT Cloud) .
  • These innovations promise to provide the most convenient and user-oriented way to monitor and manage our health, all in ultra-slim, user-friendly AIoT solutions.
  • dBio invites you to experience the future of health and exercise innovation at Medica 2023, from November 13 to November 16 in Düsseldorf.

Medica’s Board of Directors Names Lisa Erickson as President and Chief Executive Officer

Retrieved on: 
Mittwoch, November 1, 2023
Nursing, Practice Management, Professional Services, Managed Care, Health, General Health, Mental Health, Health Insurance, Hospitals, Insurance, Telemedicine, Virtual Medicine, Optimism, Voice for Animals Humane Society, Committee on Finance, University, University of Wisconsin–Madison School of Education, MBA, Carlson School of Management, Trustee, Lisa, Business administration, Business, Academy of Holy Angels, SSM Health, Marketing, RMIT School of Economics, Finance and Marketing, Management, Medica

Medica’s Board of Directors today named Lisa Erickson President and Chief Executive Officer.

Key Points: 
  • Medica’s Board of Directors today named Lisa Erickson President and Chief Executive Officer.
  • Medica operates in twelve states under Medica, Dean Health Plan, and Prevea360 Health Plan brands.
  • “We are excited to have Lisa as our President and Chief Executive Officer,” said John Buck, Medica Board Chair.
  • “I’m honored by the opportunity to lead this organization that is committed to bringing our mission to life by serving our community,” said Erickson.

Greater MSP region wins designation as U.S. Tech Hub for medical technology

Retrieved on: 
Montag, Oktober 23, 2023
CHIPS, Minnesota Department of Employment and Economic Development, MN, Science, Government, White House, Shakopee Mdewakanton Sioux Community, Gener8tor, Inclusion bodies, Medtech, Commerce, SAINT, Organization, U.S. Department of Commerce Office of Security, Data science, United, Artificial intelligence, HealthPartners, EDA, Economic development, Minneapolis–Saint Paul, University of Minnesota, Machine learning, Employment, Hospital, University, White, MEDA, U.S. Department of Defense Strategy for Operating in Cyberspace, Greater, Patient, Boston Scientific, Mayo Clinic, Pharmaceutical industry, Public utility, Management, Medica, Medtronic, Allina Health

More than 20 organizations collaborated through the GREATER MSP Partnership to develop a shared strategy that will enhance U.S. economic and national security by advancing the country’s global leadership in medical device technology.

Key Points: 
  • More than 20 organizations collaborated through the GREATER MSP Partnership to develop a shared strategy that will enhance U.S. economic and national security by advancing the country’s global leadership in medical device technology.
  • Many coalition partners gathered Monday afternoon at GREATER MSP’s office in downtown Saint Paul to participate in the live White House announcement.
  • “This is a major win for the region and state,” said Peter Frosch, President and CEO of the GREATER MSP Partnership.
  • “This designation is a national bet on the plan our region and state developed to build the next frontier of medical technology.